Analgesic formulations having enhanced therapeutic activity
US3992541A · kind A · utility
3Cited by
3References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 4, 1975 |
| Grant date | Nov 16, 1976 |
| Priority date | — |
| Expiry date | Aug 4, 1995 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application describes analgesic formulations including d 2-(6-methoxy-2-naphthyl)propionic acid, or a pharmaceutically acceptable salt or ester thereof, in combination with at least one central nervous system active analgesic compound. Analgesic activity of the combination is greater than that obtained with either of the components alone, thus demonstrating enhanced analgesia which can be obtained therewith.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.